Ultralife (NASDAQ:ULBI - Get Free Report) is expected to post its Q2 2025 quarterly earnings results before the market opens on Thursday, July 24th. Analysts expect Ultralife to post earnings of $0.14 per share and revenue of $51.00 million for the quarter.
Ultralife (NASDAQ:ULBI - Get Free Report) last announced its earnings results on Friday, May 9th. The technology company reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.02). Ultralife had a return on equity of 4.61% and a net margin of 3.05%. The company had revenue of $50.75 million for the quarter, compared to the consensus estimate of $54.50 million. During the same period in the previous year, the company earned $0.21 EPS.
Ultralife Stock Performance
Shares of ULBI stock traded down $0.14 during trading hours on Friday, reaching $8.69. 37,835 shares of the company's stock were exchanged, compared to its average volume of 73,590. Ultralife has a fifty-two week low of $4.07 and a fifty-two week high of $12.40. The stock has a market capitalization of $144.51 million, a P/E ratio of 27.16 and a beta of 1.00. The business has a fifty day moving average price of $7.45 and a 200-day moving average price of $6.57. The company has a quick ratio of 1.70, a current ratio of 3.22 and a debt-to-equity ratio of 0.37.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen upgraded Ultralife from a "buy" rating to a "strong-buy" rating in a report on Friday, June 6th.
Get Our Latest Analysis on ULBI
Insider Buying and Selling
In other Ultralife news, Director Thomas Louis Saeli purchased 5,000 shares of the business's stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $5.44 per share, for a total transaction of $27,200.00. Following the completion of the acquisition, the director directly owned 85,000 shares in the company, valued at $462,400. This represents a 6.25% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bradford T. Whitmore purchased 16,063 shares of the business's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $5.47 per share, with a total value of $87,864.61. Following the completion of the acquisition, the director owned 1,045,947 shares of the company's stock, valued at approximately $5,721,330.09. The trade was a 1.56% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 47,140 shares of company stock valued at $256,355. Corporate insiders own 40.00% of the company's stock.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Ultralife stock. Jones Financial Companies Lllp lifted its position in Ultralife Corporation (NASDAQ:ULBI - Free Report) by 1,428.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,287 shares of the technology company's stock after purchasing an additional 14,287 shares during the quarter. Jones Financial Companies Lllp owned 0.09% of Ultralife worth $82,000 at the end of the most recent reporting period. 30.68% of the stock is currently owned by institutional investors.
Ultralife Company Profile
(
Get Free Report)
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Further Reading

Before you consider Ultralife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.
While Ultralife currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.